Recent Finacing
Recent Raise
DMD Therapeutics is a Seattle-based biotech developing proprietary therapeutics for Duchenne muscular dystrophy, advancing its lead candidate DMD-813 toward preclinical and early drug development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
